Finding the safest approach to hyperemesis
Pregnant patients with severe nausea and vomiting should probably not be managed with a peripherally inserted central catheter (PICC), suggests a relatively small trial presented at this year's American College of Obstetricians and Gynecologists meeting.
Pregnant patients with severe nausea and vomiting should probably not be managed with a peripherally inserted central catheter (PICC), suggests a relatively small trial presented at this year's American College of Obstetricians and Gynecologists meeting. Comparing PICCs, nasogastric tubes (Dobhoff), and medication alone, clinicians from the University of Utah found there were no differences with respect to gestational age at delivery, Apgar scores, or average birthweight. But maternal complications were significantly worse in the PICC group (P<0.001), contributing to infection, deep vein thrombosis, or both in 45.8% of the patients.
While the numbers on fetal complications were too small to generate any statistically meaningful conclusions, the investigators did find the admission rate to the neonatal intensive care unit was 12.5% (3/24) in the PICC group, versus 6% (2/33) in the medication group, and no admissions in the NG tube group. Similarly, intrauterine growth restriction occurred in 8.3% (2/24) of the PICC group, while neither the Dobhoff nor medication group experienced IUGR.
Holmgren CM, Silver RM, Porter TF et al. Comparison or treatments for pregnancies affected with hyperemesis. Obstet Gynecol. 2006;107(4 suppl.):92S.
Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
November 28th 2023A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
Read More
Late-preterm antenatal corticosteroid treatment in twin pregnancies and newborn morbidity
November 27th 2023A recent retrospective cohort study found that administering antenatal corticosteroids from 34 to 36 weeks of gestation did not decrease composite neonatal respiratory morbidity in twin pregnancies, challenging conventional practices for this high-risk population.
Read More
The impact of WIC enrollment on breastfeeding rates: A comprehensive study
November 21st 2023Explore the findings of a recent study, revealing that enrollment in the Special Supplemental Nutritional Program for Women, Infants, and Children may influence breastfeeding decisions, shedding light on disparities and suggesting the need for targeted initiatives to enhance breastfeeding rates among low-income mothers.
Read More
